PDA-002 (human placenta-derived cells)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PDA-002 (human placenta-derived cells), covering 2022-02-02 to 2022-02-02. Get the full timeline:
Most recent: Clinical Trial Update: A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy [Phase 2]